Mehmet Akif ÖZGÜL, Efsun Gonca UĞUR CHOUSEİN, Demet TURAN, Ekrem Cengiz SEYHAN, Erdoğan ÇETİNKAYA, Deniz DOĞAN

What have we learned in interventional pulmonology in the past decade?

Background/aim: The increasing number of lung diseases and particularly pulmonary malignancies has intensified the need fordiverse interventions in the field of interventional pulmonology. In recent years we have seen many new developments and expandingapplications in the field of interventional pulmonology. This has resulted in an increased number and variety of performed proceduresand differing approaches. The purpose of the present study is to provide information on patient characteristics, range of interventions,complication rates, and the evolving approach of an experienced center for interventional pulmonology.Materials and methods: We retrospectively examined the records of 1307 patients who underwent a total of 2029 interventionalprocedures in our interventional pulmonology department between January 2008 and December 2017.Results: About half of the interventional procedures (47.2%) were performed on patients with airway stenosis due to malignant disease.Among patients with benign airway stenosis, the most frequent reason for intervention was postintubation tracheal stenosis. Thenumber of patients who developed complications was 81 (6.2%), and the most common complication was hemorrhage (n = 31, 2.99%);94.9% (n = 1240) of interventional procedures were performed under general anesthesia, without complications or deaths associatedwith anesthesia. Only one death (0.076%) occurred in the perioperative period. A total of 18 patients (1.38%) died in the 30-dayperioperative and postoperative period. None of the patients with benign airway stenosis died.Conclusion: Interventional bronchoscopy is an invasive but considerably safe and efficient procedure for selected cases and effectivetreatment modality for airway obstructions, massive hemoptysis, and foreign body aspiration. Interventional pulmonology is a fieldof pulmonary medicine that needs effort to progress and provide an opportunity to witness relevant developments, and increase thenumber of competent physicians and centers.

PDF

___

1. Zollner F. Gustav Killian, father of bronchoscopy. Archives of Otolaryngology: Head & Neck Surgery 1965; 82(6): 686-659.
2. Bolliger CT, Mathur PN. Interventional Bronchoscopy. Progress in Respiratory Research, Vol. 30. Basel, Switzerland: S Karger Publishers, 1999.
3. Ikeda S, Yanai N, Ishikawa S. Flexible bronchofiberscope. Keio Journal of Medicine 1968; 17: 1-16.
4. Ginsberg RJ, Vokes EE, Rosensweig K. Non-small cell lung cancer. In: DeVita V, Hellman S, Rosenberg S. Cancer: Principles and Practice of Oncology 5th ed. Philadelphia, PA, USA: Lippincott-Raven, 1997; pp. 858-911.
5. Grillo HC, Donahue DM, Mathisen DJ, Wain JC, Wright CD. Post-intubation tracheal stenosis: Treatment and results. Journal of Thoracic and Cardiovascular Surgery 1995; 109(3): 486-492.
6. Flandes J, Francisco JS, Cordovilla R, Cases E, Alfayate J. Bronchoscopic lung volume reduction. Clinics in Chest Medicine 2018; 39(1): 169-180. doi: 10.1016/j.ccm.2017.11.013
7. Kropski JA, Pritchett JM, Mason WR, Sivarajan L, Gleaves LA et al. Bronchoscopic cryobiopsy for the diagnosis of diffuse parenchymal lung disease. PLoS One 2013; 12;8(11): e78674. doi: 10.1371/journal.pone.0078674. eCollection 2013.
8. Linhas R, Marçôa R, Oliveira A, Almeida J, Neves S et al. Transbronchial lung cryobiopsy: Associated complications. Revista Portuguesa Pneumologia (English edition) 2017; 23(6): 331-337. doi: 10.1016/j.rppnen.2017.07.001
9. Asimakopoulos G, Beeson J, Evans J, Maiwand MO. Cryosurgery for malignant endobronchial tumors: analysis of outcome. Chest 2005; 127(6): 2007-2014. doi: 10.1378/ chest.127.6.2007
10. Ernst A, Simoff M, Ost D, Goldman Y, Herth FJF. Prospective risk-adjusted morbidity and mortality outcome analysis after therapeutic bronchoscopic procedures: results of a multiinstitutional outcomes database. Chest 2008; 134(3): 514-519. doi: 10.1378/chest.08-0580
11. Ost DE, Ernst A, Grosu HB, Lei X, Diaz-Mendoza J et al. Complications following therapeutic bronchoscopy for malignant central airway obstruction: results of the AQuIRE registry. Chest 2015; 148(2): 450-471. doi: 10.1378/ chest.14-1530
12. Gjevre JA, Myers JL, Prakash UBS. Pulmonary hamartomas. Mayo Clinic Proceedings 1996; 71(1): 14-20. doi: 10.4065/71.1.14
13. Koshkareva Y, Gaughan JP, Soliman AM. Risk factors for adult laryngotracheal stenosis: a review of 74 cases. Annals of Otology, Rhinology & Laryngology 2007; 116(3): 206-210. doi: 10.1177/000348940711600308
14. Gelbard A, Francis DO, Sandulache VC, Simmons JC, Donovan DT et al. Causes and consequences of adult laryngotracheal stenosis. Laryngoscope 2015; 125(5): 1137-1143. doi:10.1002/ lary.24956
15. Shofer SL, Wahidi MM, Davis WA, Palmer SM, Hartwig MG, et al. Significance of and risk factors for the development of central airway stenosis after lung transplantation. American Journal of Transplantation 2013; 13(2): 383-389. doi: 10.1111/ ajt.12017
16. Alvarez A, Algar J, Santos F, Lama R, Atanda JL et al. Airway complications after lung transplantation: a review of 151 anastomoses. European Journal of Cardio-Thoracic Surgery 2001; 19(4): 381-387. doi: 10.1016/S1010-7940(01)00619-4
17. Valipour A, Kreuzer A, Koller H, Koessler W, Burghuber OC. Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemoptysis. Chest 2005; 127(6): 2113-2118. doi: 10.1378/chest.127.6.2113.
18. Hirshberg B, Biran I, Glazer M, Kramer MR. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest 1997; 112(2): 440-444. doi:10.1378/chest.112.2.440
19. Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA et al. Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis. American Journal of Roentgenology 2001; 177(4): 861-867. doi: 10.2214/ ajr.177.4.1770861
20. Conlan AA, Hurwitz SS: Management of massive haemoptysis with the rigid bronchoscope and cold saline lavage. Thorax 1980; 35(12): 901-904. doi: 10.1136/thx.35.12.901
21. Rahman NM, Ali NJ, Brown G, Chapman SJ, Davies RJO, et al. Local anaesthetic thoracoscopy. In: British Thoracic Society Pleural Disease Guideline. Thorax 2010; 65(2): ii54-ii60. doi: 10.1136/thx.2010.136978
22. Ahmed SNM, Saka H, Mohammadien HA, Alkady O, Oki M et al. Safety and complications of medical thoracoscopy. Advances in Medicine 2016; Article ID 3794791:6 pages. doi: 10.1155/2016/3794791
23. Ramirez J. Alveolar proteinosis: importance of pulmonary lavage. American Review of Respiratory Disease 1971; 103(5): 666-678. doi: 10.1164/arrd.1971.103.5.666
24. Campo I, Luisetti M, Griese M, Trapnell BC, Bonella F et al. Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures. Orphanet Journal of Rare Diseases 2016; 11(1): 115. doi:10.1186/s13023- 016-0497-9
25. Gay P, Wallaert B, Nowak S, Yserbyt J, Anevlavis S et al. Efficacy of whole-lung lavage in pulmonary alveolar proteinosis: a multicenter international study of GELF. Respiration 2017; 93(3): 198-206. doi: 10.1159/000455179
26. Babiak A, Hetzel J, Krishna G, Fritz P, Moeller P et al. Transbronchial cryobiopsy: a new tool for lung biopsies. Respiration 2009; 78: 203-208. doi: 10.1159/000203987
27. Ravaglia C, Bonifazi M, Wells AU, Tomassetti S, Gurioli C et al. Safety and diagnostic yield of transbronchial lung cryobiopsy in diffuse parenchymal lung diseases: a comparative study versus video-assisted thoracoscopic lung biopsy and a systematic review of the literature. Respiration 2016; 91(3): 215-227. doi: 10.1159/000444089
28. Hetzel J, Maldonado F, Ravaglia C, Wells AU, Colby TV et al. Transbronchial cryobiopsies for the diagnosis of diffuse parenchymal lung diseases: expert statement from the cryobiopsy working group on safety and utility and a call for standardization of the procedure. Respiration 2018; 95(3): 188- 200. doi: 10.1159/000484055